Emily is originally from upstate New York and attended college at Trinity College in Connecticut. She graduated from Trinity with honors in chemistry and participated in a summer internship in Pharmacology and Preclinical Development at Tularik Inc. (currently Amgen) in South San Francisco. She then obtained her Ph.D. from the University of California, Berkeley. At Berkeley, Emily completed her graduate studies with Prof. Michael A. Marletta where she focused on the biochemical study of an enzyme relevant to human health. For her postdoctoral studies, she conducted research in Prof. Jon Clardy’s lab at Harvard Medical School. At Harvard, Emily developed a chemical genetic screen to discover inhibitors of liver stage malaria as a NIH postdoctoral fellow.
Emily joined the Duke University faculty in 2014. She is an Assistant Professor in the Department of Chemistry and has a secondary appointment in the Department of Molecular Genetics & Microbiology. Her goals are to address global health issues by working at the interface of chemistry and biology.
Emily has been the recipient of the NIH Pathway to Independence Award (K99/R00), the Ralph E. Powe Junior Faculty Award, the Keystone Young Investigator Award, and the AAAS Marion Milligan Mason Award.